On the heels of Movember, the month-long initiative where people raise awareness for a host of men’s health issues including prostate awareness and sexual health, Rocky Mountain Urology Center at Valley View is pleased to announce that it is the first in the Western Slope of Colorado to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
Rocky Mountain Urology Center’s physicians are experts in general urology and have subspecialty experience in urologic cancers, female urology and kidney stone disease. As the only full-time urology practice, the Rocky Mountain Urology Center is the most comprehensive urology group in the region, from Roaring Fork Valley and Vail to De Bequeu. With two board-certified urologists, Aashish Kabra, MD and Jamie Lowe, MD, and a nurse practitioner, Ashley Gilley, ANP, the Center provides the most regional coverage with locations in Aspen, Eagle, Rifle, and Glenwood Springs, reducing travel and wait times. Additionally, a third board-certified urologist will join the team in early 2023, Scott Castle, MD, expanding care and coverage to the community.
BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown to be larger than normal. One in two men ages 51 to 60 have BPH, and the incidence increases every decade of life. If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones and incontinence. The problem with BPH surgical treatments today is that they often force men to tradeoff between symptom relief and side effects, limiting patients to choose between either a high degree of symptom relief with high rates of irreversible complications (such as incontinence, erectile dysfunction, or ejaculatory dysfunction) or low degree of symptom relief with low rates of irreversible complications.
Aquablation therapy is a different type of treatment for BPH. It’s an advanced, minimally invasive treatment that uses the power of water delivered with robotic precision to provide best-in-class and long-lasting symptom relief with low rates of irreversible complications, regardless of prostate size or shape.
“We are proud to be among the first in the state of Colorado to offer a solution for men with benign prostatic hyperplasia (BPH) that provides BPH relief without compromise,” said Aashish Kabra, MD, general urologist at Rocky Mountain Urology Center at Valley View. “Both Jamie Lowe, MD and I specialize in BPH and bring great expertise to the procedure. Aquablation therapy allows us to take a less invasive approach and ensures more precision. Adding this cutting-edge service to our Urology Center will help improve our patients’ quality of life and further our commitment to men’s health.”
Aquablation therapy is performed by the AquaBeam Robotic System, the first FDA-cleared, surgical robot utilizing automated tissue resection or the treatment of LUTS due to BPH. It combines real-time, multi-dimensional imaging, automated robotic technology, and heat-free waterjet ablation technology for targeted, controlled, and immediate removal of prostate tissue. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy, prostate size or surgeon experience.
Aquablation therapy has proven results. In clinical studies, Aquablation therapy has been shown to provide both best-in-class and durable symptom relief with low rates of irreversible complications.
A study within the Journal of Sexual Medicine, which surveyed 300 men living with BPH, revealed that 92% of respondents expressed interest in learning more about Aquablation therapy. This data demonstrates the need within the patient population to find relief without the trade-off between symptoms and relief side effects.
For more information about the Rocky Mountain Urology Center at Valley View, visit vvh.org/urology/.
For more information on Aquablation therapy, visit aquablation.com.
About Valley View
Valley View is an independent, not-for-profit health system based in Glenwood Springs, Colorado. Founded in 1955 with funds raised by the community, Valley View Hospital has evolved to serve the healthcare needs of the region. In addition to its 78-bed hospital in Glenwood Springs, Valley View now includes an integrated system of specialty centers and physicians practices providing care in multiple locations across Garfield, Pitkin, Eagle and Mesa counties. Cardiovascular care, including open heart surgery, comprehensive cancer care, neurosurgical and orthopedic care, provide a level of specialty care that enable patients to stay close to home for key healthcare needs. A network of primary care practices support optimal health and the management of patients’ total health. As part of Valley View’s commitment to the community, it hosts health fairs, blood drives, a Kids & Teen Safety Fair and physician-led education series. Valley View has been recognized for performance excellence from Healthgrades, J.D. Power & Associates, Truven Health “Top 100 Hospitals”, Planetree, Survey Vitals and Consumer Reports. PeopleCare. That’s Valley View. www.vvh.org
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics is a surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on BPH, the AquaBeam Robotic System delivering Aquablation therapy is the first FDA-cleared, surgical robot utilizing automated tissue resection for the treatment of lower urinary tract symptoms due to BPH. Aquablation therapy combines real-time, multi-dimensional imaging, automated robotic technology, and heat-free waterjet ablation technology for targeted, controlled, and immediate removal of prostate tissue. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy, prostate size, or surgeon experience. For more information visit https://www.procept-biorobotics.com.
Important Safety Information
All surgical treatments have inherent and associated side effects. The most common side effects are mild and transient, and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. For more information about potential side effects and risks associated with Aquablation therapy, speak with your urologist or surgeon. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.
